Senior insider sale
President and CEO at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$9.45M
102.97K shares
What this filing means
PATEL DINESH V PH D plans to sell 102.97K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $9.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/24/2026ACC: 0001968582-26-000318
DirectorOfficer· President and CEO
Since Jul 2018
102.97K
Shares to sell
$9.45M
Approx. market value
54.70K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Option Exercise
Cash
3/24/2026
54.70KTotal acquired54.70K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/24/2026 | Option Exercise Cash | 54.70K | — |
| Total | 54.70K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.07K
Market value
$338.4K
1/27/2026
—Completed
Units to sell
24.89K
Market value
$2.09M
1/26/2026
—Completed
Units to sell
19.32K
Market value
$1.63M
1/23/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
54.70K
Market value
$5.39M
3/24/2026
Total
Units
102.97K
Value
$9.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/27/2026 | 4.07K | $338.4K | — | Completed |
1/26/2026 | 24.89K | $2.09M | — | Completed |
1/23/2026 | 19.32K | $1.63M | — | Completed |
| Planned — Approximate Date | ||||
3/24/2026 | 54.70K | $5.39M | Nasdaq | Planned |
| Total | 102.97K | $9.45M | ||